"Cholangiocarcinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant tumor arising from the epithelium of the BILE DUCTS.
Descriptor ID |
D018281
|
MeSH Number(s) |
C04.557.470.200.025.450
|
Concept/Terms |
Cholangiocarcinoma- Cholangiocarcinoma
- Cholangiocarcinomas
- Cholangiocellular Carcinoma
- Carcinoma, Cholangiocellular
- Carcinomas, Cholangiocellular
- Cholangiocellular Carcinomas
Extrahepatic Cholangiocarcinoma- Extrahepatic Cholangiocarcinoma
- Cholangiocarcinoma, Extrahepatic
- Cholangiocarcinomas, Extrahepatic
- Extrahepatic Cholangiocarcinomas
Intrahepatic Cholangiocarcinoma- Intrahepatic Cholangiocarcinoma
- Cholangiocarcinoma, Intrahepatic
- Cholangiocarcinomas, Intrahepatic
- Intrahepatic Cholangiocarcinomas
|
Below are MeSH descriptors whose meaning is more general than "Cholangiocarcinoma".
Below are MeSH descriptors whose meaning is more specific than "Cholangiocarcinoma".
This graph shows the total number of publications written about "Cholangiocarcinoma" by people in this website by year, and whether "Cholangiocarcinoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2016 | 6 | 0 | 6 |
2017 | 39 | 3 | 42 |
2018 | 34 | 4 | 38 |
2019 | 16 | 3 | 19 |
2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Cholangiocarcinoma" by people in Profiles.
-
Nopp140-chaperoned 2'-O-methylation of small nuclear RNAs in Cajal bodies ensures splicing fidelity. Genes Dev. 2021 08 01; 35(15-16):1123-1141.
-
Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease. Aging (Albany NY). 2021 06 27; 13(12):15785-15800.
-
Changing surgical practice in management of intrahepatic cholangiocarcinoma during the pandemic. Is bridging with systemic therapy safe for our patients? Br J Surg. 2021 04 05; 108(3):e145.
-
Effect of COVID-19 outbreak on community screening program for cancer prevention: A note from endemic area of cholangiocarcinoma. J Cancer Res Ther. 2021 Apr-Jun; 17(2):576.
-
Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient. J Med Virol. 2021 04; 93(4):1940-1942.
-
Unchanged surgical management of patients with Cholangiocarcinoma during the COVID-19 pandemic. Dig Liver Dis. 2020 09; 52(9):944-945.
-
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective. Lancet Gastroenterol Hepatol. 2020 08; 5(8):765-775.
-
Intrahepatic Cholangiocarcinoma. Surg Oncol Clin N Am. 2019 10; 28(4):587-599.
-
Reply to: "Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma". J Hepatol. 2019 12; 71(6):1262-1263.
-
Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study. Anticancer Res. 2019 Jun; 39(6):3095-3100.